TRVI
TREVI THERAPEUTI (TRVI)
NASDAQ
$13.85+$1.08 (+8.46%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $1.8B
    Market Cap
  • 17.26%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 6
Valuation
TRVI
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 50
Valuation
TRVI
vs History
vs S&P 500
3-Month Momentum
-16.17%
12-Month Momentum
43.10%
3-Month Risk Adjusted Momentum
-106.14%
12-Month Risk Adjusted Momentum
76.89%

True Yield

N/A
Valuation
TRVI
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-2.30%

Financial Health Score

Score: 46
Valuation
TRVI
vs History
vs S&P 500
Ohlson's O-Score
-2